TY - JOUR
T1 - Occult bilateral involvement in Stage I epithelial ovarian cancer
AU - Benjamin, Ivor
AU - Morgan, Mark A.
AU - Rubin, Stephen C.
N1 - Copyright 1999 Academic Press.
PY - 1999/3
Y1 - 1999/3
N2 - Objective: The aim of this study was to determine the incidence of occult bilateral involvement in Stage I epithelial ovarian cancer. Methods. We retrospectively reviewed the records of all patients (n = 135) with Stage I epithelial ovarian cancer treated at the University of Pennsylvania Cancer Center between 1985 and 1996. A study group of patients (n = 118) who underwent a bilateral salpingo-oophorectomy as part of their staging laparotomy was identified. Operative notes, pathology reports, and discharge summaries were reviewed to document stage, grade, histology, intraoperative impression, gross pathological description, and microscopic diagnosis. Clinically occult bilateral involvement was defined as pathologically documented ovarian involvement by tumor in an ovary that appeared normal to the surgeon during staging laparotomy. Results. The study group consisted of mostly Stage IA (79/118, 67%), followed by Stage IC (35/118, 30%) and Stage IB (4/118, 3%), tumors. In 9/118 (7.6%) of these cases, bilateral disease was documented in the pathology report. In 3/118 (2.5%) of these cases, the bilateral involvement by tumor was clinically occult at the time of surgery. In only 1/118 (0.85%) of these cases did a clinically abnormal appearing ovary not contain tumor. Conclusion. Occult involvement by early ovarian cancer is uncommon at the time of staging laparotomy. In appropriately counseled patients strongly desiring to preserve fertility, a unilateral salpingo-oophorectomy may be considered as part of a staging procedure for apparent Stage IA epithelial ovarian cancer if the contralateral ovary appears normal to the surgeon. Consideration should be given to a wedge biopsy with intraoperative frozen section to help exclude occult disease in the normal appearing ovary.
AB - Objective: The aim of this study was to determine the incidence of occult bilateral involvement in Stage I epithelial ovarian cancer. Methods. We retrospectively reviewed the records of all patients (n = 135) with Stage I epithelial ovarian cancer treated at the University of Pennsylvania Cancer Center between 1985 and 1996. A study group of patients (n = 118) who underwent a bilateral salpingo-oophorectomy as part of their staging laparotomy was identified. Operative notes, pathology reports, and discharge summaries were reviewed to document stage, grade, histology, intraoperative impression, gross pathological description, and microscopic diagnosis. Clinically occult bilateral involvement was defined as pathologically documented ovarian involvement by tumor in an ovary that appeared normal to the surgeon during staging laparotomy. Results. The study group consisted of mostly Stage IA (79/118, 67%), followed by Stage IC (35/118, 30%) and Stage IB (4/118, 3%), tumors. In 9/118 (7.6%) of these cases, bilateral disease was documented in the pathology report. In 3/118 (2.5%) of these cases, the bilateral involvement by tumor was clinically occult at the time of surgery. In only 1/118 (0.85%) of these cases did a clinically abnormal appearing ovary not contain tumor. Conclusion. Occult involvement by early ovarian cancer is uncommon at the time of staging laparotomy. In appropriately counseled patients strongly desiring to preserve fertility, a unilateral salpingo-oophorectomy may be considered as part of a staging procedure for apparent Stage IA epithelial ovarian cancer if the contralateral ovary appears normal to the surgeon. Consideration should be given to a wedge biopsy with intraoperative frozen section to help exclude occult disease in the normal appearing ovary.
KW - Adenocarcinoma/pathology
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Diagnosis, Differential
KW - Female
KW - Humans
KW - Medical Records
KW - Middle Aged
KW - Neoplasm Metastasis
KW - Neoplasm Staging
KW - Ovarian Neoplasms/pathology
KW - Retrospective Studies
UR - http://www.scopus.com/inward/record.url?scp=0032980462&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000079015900004&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1006/gyno.1998.5260
DO - 10.1006/gyno.1998.5260
M3 - Article
C2 - 10053097
SN - 0090-8258
VL - 72
SP - 288
EP - 291
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 3
ER -